(Total Views: 163)
Posted On: 03/31/2022 1:26:35 PM
Post# of 23603
$AVCO Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
https://finance.yahoo.com/news/avalon-globoca...00211.html
https://finance.yahoo.com/news/avalon-globoca...00211.html
(0)
(0)Scroll down for more posts ▼
